LISA BROWN: Open Payments
NPI 1396070629 · PORTERVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 17 payments from 7 companies in 2025. Trend: 2023 $281 · 2024 $360 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABBVIE INC. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: REXULTI, MOUNJARO, VOQUEZNA, AIRSUPRA, VRAYLAR, JARDIANCE, Veozah, FARXIGA.
Industry payments across CA — which companies pay providers there.
